相似文献
1
The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease.右兰索拉唑缓释剂在胃食管反流病管理中的作用。
Therap Adv Gastroenterol. 2017 Feb;10(2):243-251. doi: 10.1177/1756283X16681701. Epub 2017 Jan 5.
2
Delayed release dexlansoprazole in the treatment of GERD and erosive esophagitis.缓释型右兰索拉唑治疗胃食管反流病和糜烂性食管炎。
Clin Exp Gastroenterol. 2009;2:117-28. doi: 10.2147/ceg.s5765. Epub 2009 Nov 17.
3
Managing gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MR.管理胃食管反流病——右兰索拉唑缓释片的比较疗效与结果
Ther Clin Risk Manag. 2015 Oct 30;11:1649-56. doi: 10.2147/TCRM.S66680. eCollection 2015.
4
Dexlansoprazole MR: a review.多廿烷醇：综述。
Ann Med. 2011 Aug;43(5):366-74. doi: 10.3109/07853890.2011.554429. Epub 2011 Mar 3.
5
Dexlansoprazole modified release: in erosive oesophagitis and non-erosive reflux disease.多廿烷醇：在糜烂性食管炎和非糜烂性反流病中的应用。
Drugs. 2010 Aug 20;70(12):1593-601. doi: 10.2165/11295960-000000000-00000.
6
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole.用于治疗糜烂性食管炎和胃食管反流病患者的质子泵抑制剂：右兰索拉唑的现有证据及安全性
Clin Exp Gastroenterol. 2016 Jul 13;9:163-72. doi: 10.2147/CEG.S91602. eCollection 2016.
7
Dexlansoprazole for the treatment of esophagitis and GERD.右兰索拉唑用于治疗食管炎和胃食管反流病。
Drugs Today (Barc). 2010 Feb;46(2):75-80. doi: 10.1358/dot.2010.46.2.1437714.
8
The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole.体重指数增加对烧心严重程度、频率的影响以及对多潘立酮或雷贝拉唑治疗的反应。
Aliment Pharmacol Ther. 2013 Apr;37(8):810-8. doi: 10.1111/apt.12270. Epub 2013 Mar 4.
9
Comparison of the efficiency of two different proton pump inhibitor formula in treatment of patients with atypical gastroesophageal reflux disease: a prospective randomized study.两种不同质子泵抑制剂配方治疗非典型胃食管反流病患者的疗效比较：一项前瞻性随机研究。
J Gastroenterol Hepatol. 2020 Dec;35(12):2096-2102. doi: 10.1111/jgh.15093. Epub 2020 May 19.
10
Dexlansoprazole in the treatment of esophagitis and gastroesophageal reflux disease.多潘立酮治疗食管炎和胃食管反流病。
Ann Pharmacother. 2010 May;44(5):871-7. doi: 10.1345/aph.1M685. Epub 2010 Apr 6.
引用本文的文献
1
Childhood gastroesophageal reflux disease: A comprehensive review of disease, diagnosis, and therapeutic management.儿童胃食管反流病：疾病、诊断及治疗管理的全面综述
World J Clin Pediatr. 2025 Jun 9;14(2):101175. doi: 10.5409/wjcp.v14.i2.101175.
2
Evaluation of the Susceptibility of Bangladeshi University Students to Gastroesophageal Reflux Disease (GERD) and Its Associated Factors: A Cross-Sectional Study.孟加拉国大学生胃食管反流病（GERD）易感性及其相关因素评估：一项横断面研究。
Health Sci Rep. 2025 Apr 16;8(4):e70646. doi: 10.1002/hsr2.70646. eCollection 2025 Apr.
3
Comparative Efficacy of Dexlansoprazole, Pantoprazole, Esomeprazole, and Rabeprazole in Achieving Optimal 24-Hour Intragastric pH Control: A Randomized Crossover Study Using Ambulatory pH Monitoring.右兰索拉唑、泮托拉唑、埃索美拉唑和雷贝拉唑在实现最佳24小时胃内pH值控制方面的疗效比较：一项使用动态pH监测的随机交叉研究。
Cureus. 2024 Oct 14;16(10):e71418. doi: 10.7759/cureus.71418. eCollection 2024 Oct.
4
Efficacy of Shugan Hewei formula combined with rabeprazole in refractory gastroesophageal reflux disease: randomized, double-blind, placebo-controlled trial.疏肝和胃方联合雷贝拉唑治疗难治性胃食管反流病的疗效：随机、双盲、安慰剂对照试验。
Eur J Med Res. 2024 Sep 19;29(1):466. doi: 10.1186/s40001-024-02030-z.
5
Efficacy of a Food Supplement Containing LA14, Peptides, and a Multivitamin Complex in Improving Gastroesophageal Reflux Disease-Related Outcomes and Quality of Life of Subjects Showing Mild-to-Moderate Gastroesophageal Reflux Disease.LA14、肽和多种维生素复合物的食品补充剂对改善轻度至中度胃食管反流病患者胃食管反流病相关结局和生活质量的疗效。
Nutrients. 2024 Jun 4;16(11):1759. doi: 10.3390/nu16111759.
6
Evaluation of the impact of oesophageal reflux disease on muscle fatigue.评估食管反流病对肌肉疲劳的影响。
Eur J Transl Myol. 2024 May 30;34(2):12243. doi: 10.4081/ejtm.2024.12243.
7
Real-World Evidence to Evaluate the Efficacy and Safety of Vonoprazan in Gastrointestinal Disorders in the Pakistani Population.评估沃克帕唑在巴基斯坦人群胃肠道疾病中的疗效和安全性的真实世界证据。
Cureus. 2023 Nov 18;15(11):e48994. doi: 10.7759/cureus.48994. eCollection 2023 Nov.
8
Epidemiology, Causes, and Management of Gastro-esophageal Reflux Disease: A Systematic Review.胃食管反流病的流行病学、病因及管理：一项系统评价
Cureus. 2023 Oct 21;15(10):e47420. doi: 10.7759/cureus.47420. eCollection 2023 Oct.
9
Development of Novel Balloon-Integrated Optical Catheter for Endoscopic and Circumferential Laser Application.新型球囊集成式光学内镜和环周激光应用导管的研制
Ann Biomed Eng. 2023 Sep;51(9):2021-2034. doi: 10.1007/s10439-023-03228-8. Epub 2023 May 16.
10
Revision paraesophageal hernia repair outcomes in patients with typical and atypical reflux.典型和非典型反流患者的食管裂孔疝修补术治疗效果的评估。
Surg Endosc. 2023 Jun;37(6):4947-4953. doi: 10.1007/s00464-022-09635-7. Epub 2022 Oct 3.
本文引用的文献
1
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection.一项基于右兰索拉唑缓释片的三联疗法治疗幽门螺杆菌感染的随机对照试验性研究
Medicine (Baltimore). 2016 Mar;95(11):e2698. doi: 10.1097/MD.0000000000002698.
2
Unmet Needs in the Treatment of Gastroesophageal Reflux Disease.胃食管反流病治疗中未满足的需求
J Neurogastroenterol Motil. 2015 Jul 30;21(3):309-19. doi: 10.5056/jnm15105.
3
High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand.基于左氧氟沙星-右兰索拉唑的四联疗法作为泰国幽门螺杆菌根除一线治疗的高效性
Asian Pac J Cancer Prev. 2015;16(10):4353-6. doi: 10.7314/apjcp.2015.16.10.4353.
4
High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections.高剂量缓释兰索拉唑（右兰索拉唑）与阿莫西林联合治疗幽门螺杆菌感染
Helicobacter. 2014 Aug;19(4):319-22. doi: 10.1111/hel.12126. Epub 2014 Apr 3.
5
Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease.区分多潘立酮对胃食管反流病患者烧心与反流的影响。
Aliment Pharmacol Ther. 2013 Nov;38(10):1303-11. doi: 10.1111/apt.12504. Epub 2013 Sep 30.
6
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.胃食管反流病的流行病学更新：系统评价。
Gut. 2014 Jun;63(6):871-80. doi: 10.1136/gutjnl-2012-304269. Epub 2013 Jul 13.
7
Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease.随机对照试验的间接比较：在治疗胃食管反流病方面，达克普隆（右旋兰索拉唑）与埃索美拉唑的疗效比较。
Aliment Pharmacol Ther. 2013 Jul;38(2):190-201. doi: 10.1111/apt.12349. Epub 2013 May 29.
8
Gastroesophageal reflux disease and sleep.胃食管反流病与睡眠。
Gastroenterol Clin North Am. 2013 Mar;42(1):57-70. doi: 10.1016/j.gtc.2012.11.011.
9
The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole.体重指数增加对烧心严重程度、频率的影响以及对多潘立酮或雷贝拉唑治疗的反应。
Aliment Pharmacol Ther. 2013 Apr;37(8):810-8. doi: 10.1111/apt.12270. Epub 2013 Mar 4.
10
Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.从每日两次质子泵抑制剂滴定至每日一次的盐酸多奈哌齐口腔崩解片维持烧心缓解。
Clin Gastroenterol Hepatol. 2012 Mar;10(3):247-53. doi: 10.1016/j.cgh.2011.11.021. Epub 2011 Dec 7.
Zotero 插件